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Abstract
Pentameric ligand-gated ion channels are an important class of widely expressed
membrane neuroreceptors, which play a crucial role in fast synaptic communications
and are involved in several neurological conditions. They are activated by the binding of
neurotransmitters, which trigger the transmission of an electrical signal via facilitated
ion-flux. They can also be activated, inhibited or modulated by a number of drugs. Mu-
tagenesis electrophysiology experiments, with natural or unnatural amino acids, have
provided a large body of functional data that, together with emerging structural infor-
mation from X-ray spectroscopy and cryo-electron microscopy, are helping unravel the
complex working mechanisms of these neuroreceptors. Computer simulations are com-
plementing these mutagenesis experiments, with insights at various levels of accuracy
and resolution. Here we review how a selection of computational tools, including first
principles methods, classical molecular dynamics and enhanced sampling techniques, are
contributing to construct a picture of how pentameric ligand-gated ion channels function
and can be pharmacologically targeted to treat the disorders they are responsible for.
Graphical TOC Entry
Keywords
Pentameric ligand-gated ion channels, mutagenesis electrophysiology experiments, first prin-
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Introduction
Pentameric ligand-gated ion channels (pLGICs) are membrane receptors, located at synapses,
which convert chemical signals from presynaptically released neurotransmitters into postsy-
naptic electrical signals. They mediate fast synaptic communication, which plays a crucial
role in processes like memory, learning and sensory perception. They are widely expressed in
multicellular animals, as well as in bacteria. They are associated with a variety of neurologi-
cal conditions where neuronal communication is impaired, from Alzheimer’s and Parkinson’s
disease to addiction, attention deficit disorder and schizophrenia. They are important target
sites for drugs, anaesthetics and, in invertebrates, insecticides.1–5
pLGICs share common structural features and some degree of sequence homology: a
model of a prototypical example, the serotonin (5-hydroxytryptamine, 5-HT) type 3 receptor
(5-HT3R), is shown in Fig. 1. They are composed of five identical (homo-pentameric LGICs)
or different (hetero-pentameric LGICs) subunits arranged in a cylindrical shape around an
ion permeable pore. Each subunit consists of: (i) an extracellular domain (ECD), mostly
made of β-sheets, with the β strands progressively labelled from β1; (ii) a transmembrane
domain (TMD) embedded in the cell membrane, composed by four interconnected helices
labelled as M1, M2, M3 and M4; and (iii), in some cases, an intracellular domain (ICD).
The receptors are activated by the binding of neurotransmitters at the interface between
subunits in the ECD, as shown in Fig. 2 for an exemplary case (GABA binding to the in-
sect resistance to dieldrin (RDL) receptor). It is not clear how many neurotransmitters are
needed for optimal activation, but experimental evidence suggests two or three.1,6 Neuro-
transmitter binding induces conformational changes which result in the opening (gating) of
the ion channels: ions can then pass through the membrane transmitting the electric signal
between neurons. Ion flow produces either a depolarisation response, for excitatory anionic
receptors, or a hyperpolarisation one, for inhibitory cationic receptors. The activity stops
when the channel closes due to the absence of neurotransmitters or assumes a desensitized
non-conductive state with ligands still bound.
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Examples of pLGICs include the nicotinic acetylcholine receptor (nAChR),7 GABAA and
GABAC receptors, glycine receptors (GlyR), the serotonin 5-HT3R6 shown in Fig. 1, the
eukariotic glutamate receptor GluCl, and the bacterial receptors Erwinia Chrysanthemi and
Gloeobacter Violaceus ligand-gated ion channels (ELIC and GLIC respectively). Some of
these pLGICs (e.g. nAChR, GABA receptor, GlyR and 5-HT3R) are grouped into the Cys-
loop superfamily, characterized by a disulphide bridge that joins two cysteines 13 residues
apart, forming the characteristic Cys-loop in the ECD N-terminal. Besides specific neu-
rotransmitters (e.g. acetylcholine, GABA and serotonin), these receptors can bind other
natural (e.g. nicotine for nAChR) or artificially-designed ligands, both in the orthosteric
binding sites or allosterically,8 which can activate, potentiate or impair channel function.
For example, granisetron is an antiemetic drug that blocks the activity of 5-HT3R, which
is linked to the vomiting centre,9 while benzodiazepines enhance the inhibitory effects of
GABA in the GABAA receptors, resulting in sedative, anxiolytic, anticonvulsant and muscle
relaxant effects.
Despite pLGIC medical and pharmacological importance, how the binding information
is passed from the ECD to the TMD tens of Angstroms away, to induce the opening of the
channel, is still far from being fully understood. As evident in Fig. 1 for 5-HT3R, these two
domains are topological distinct, but can communicate through a number of crucial flexible
interface loops, including the ECD Cys-loop and the TMD M2-M3 loop connecting helices
M2, which lines the channel, and M3.
Difficulties in fully unravelling the working mechanisms of pLGICs arise from their in-
trinsic complexity as well as that of the environment they are embedded in, and from the
limited available structural information, due to the challenges in crystallising and resolving
these membrane receptors. Some progress was first achieved thanks to the X-ray structure
of the acetylcholine binding protein (AChBP),10 a globular snail protein similar to the ECD
of nAChR, which thus lacks the TMD, and of a medium resolution electron microscopy
structure of nAChR from the electric ray Torpedo Marmorata.11 To achieve crystallisation,
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in many cases intracellular loops are either removed or replaced by short linkers similar to
prokaryotic Cys-loop receptors, so ICD information is often missing or incomplete, although
their role can be important, e.g. for interacting with scaffold proteins supporting synapse
formation. Given the modular nature of these receptors, single subunits or domains can
also be studied separately, although with some limitations. Recently, however, some fairly
complete and full length structures with good resolution in different functional states have
become available from X-ray spectroscopy and cryo-electron microscopy.12–26 More are likely
to be determined in the near future, providing unprecedented information and opportunities
for modelling.
Many chemical-scale insights into the relationship between structure and function of
pLGICs have been obtained by mutagenesis electrophysiology experiments, whose main goal
is to assess how mutations impact on receptor structure and function. Mutations can be
realized with natural amino acids or artificially designed compounds, to increase diversity and
tailor experiments to probe e.g. the role of specific bonds. A powerful tool for incorporating
unnatural amino acids into membrane proteins is the in vivo nonsense suppression method,
which, through a combination of organic synthesis and molecular biology, prepares novel
aminoacyl tRNAs to deliver unnatural amino acids to the ribosome,27 often using Xenopus
oocytes as expression tools. The function of mutated receptors can then be probed by
electrophysiology measurements, which are often quantified by the effective concentration
half (EC50, a functional measurement of the ligand concentration which results in a half of
the maximum response). Mutated receptors with higher EC50 either bind ligands with lower
affinity with respect to the wild-type and/or are less efficient at channel opening than those
with lower EC50.28–33 Moreover, patch clamp techniques allow recording of single-channel
kinetics in real time.34
The experimental response is, however, macroscopic: its interpretation can be supported
and improved by computer modelling, which can mimic experiments and provide otherwise
inaccessible details at the molecular level. Here, we review our work, focused on using a
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series of simulation tools of different resolution to assess the effects of mutations in pLGICs.
We also give an overview of selected work by other groups focussed on mutations in pLGICs
so to provide a more general picture.
Atomistic models of pLGICs can be built by homology, or be based on X-ray and cryo-
electron microscopy structures, when available. Given the intrinsic complexity of pLGICs,
simulation techniques of different resolution and accuracy, used individually or in combina-
tion, are needed to elucidate different aspects of pLGICs working mechanisms. Most com-
monly, these include first principles methods (specifically density functional theory, DFT),
classical molecular dynamics (MD) with all-atom force-fields, and enhanced sampling meth-
ods (in particular metadynamics): they will be expanded in the following.
Although additional techniques such as Monte Carlo simulations,35–37 coarse-grained
methods,38,39 umbrella sampling,40,41 steered MD,39 the string method42 and tunnelling cal-
culations43 are available and have been successfully used to investigate ion channels, a full
description of these is beyond the scope of this review.
The behavior of pLGICs is extremely complex and an ensemble of multiple related confor-
mations may be needed to describe a physiological state. While more experimental structural
information is progressively becoming available for pLGICs in different functional states, it is
extremely challenging to unambiguously match experimental structures to functional states
(open, closed, desensitised, inhibited etc..), due to a variety of factors, including limited
resolution, influence of detergent and/or nano-bodies, crystal packing and receptor engineer-
ing.26 Due to the still limited availability of structural models, the complexity and size of the
systems and the relatively short time scales that can be simulated, computational works like
those reviewed here are often limited to explore only one functional state of the receptor of
interest. Therefore such studies do not provide information on how the equilibrium between
different states is altered by mutations, which would be an important topic to address in
the future. Nonetheless, they prove very useful in highlighting dynamical and structural
differences between wild-type and mutated receptors.
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Figure 1: Left: Model of a prototypical pLGIC, the mouse homo-pentameric 5-HT3 receptor,
based on the X-ray structure of Ref.17 The incompletely resolved intracellular domain has
been removed, and the M3 and M4 helices have been linked with a short loop. The model
is embedded in a POPC lipid bilayer mimicking the cell membrane. Right: a single subunit
with relevant structures labelled.
Figure 2: An exemplary orthosteric binding site in a pLGIC. Left: Top view of model of the
ECD of the RDL receptor, with residues in the orthosteric binding site in red and orange.
Right: GABA in the binding site, including aromatic residues which form a “cage” around
the GABA amine group. [Adapted from Ref.44]
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First Principles Methods
First principles methods, in particular based on DFT which offers a favourable ratio between
accuracy and computational cost, can provide precise insights into the electronic structure ef-
fects produced by mutations. However, because of their computational cost, their application
is limited to small models, e.g. of the binding site of pLGICs, or to supporting calculations
to parametrise force-fields, for example for non-standard ligands and for unnatural amino
acids, to be used in extended classical MD or enhanced sampling simulations of mutated
receptors.
Neurotransmitters usually bind in zwitterionic form (with moieties of opposite charges,
e.g. GABA) or carry a positive charge (e.g. serotonin). Besides being involved in hydrogen
bonds and salt-bridges (as well as their negative counterparts), positively charged groups can
interact with the aromatic rings of amino acids like tyrosine, phenylalanine or tryptophan
through cation-pi interactions.45 A cage of aromatic amino acids is thought to often enclose
the positively charged part of the ligand in the orthosteric binding site of pLGICs as shown
in Fig. 2. Fluorination of the aromatic rings of these amino acids decreases aromaticity,
weakening cation-pi interactions as well as hydrogen bonds: it is a powerful strategy to obtain
information on the relevance of such interactions to ligand binding. These are electronic
structure effects that can be effectively captured by first principles calculations.
As an example, Fig. 3 shows electronic structure data obtained with DFT (with the
PBE exchange and correlation functional, norm-conserving Martins-Troullier pseudopoten-
tials and a plane wave basis set with a cutoff of 70 Ry) for a reduced model of the binding
site of serotonin in the 5-HT3 receptor, that we built to assess the effects of mutating spe-
cific tyrosines. The latter were modified, as in experiments, by substituting the hydroxyl
group and hydrogen atoms in the aromatic side chain with fluorine. The data in Fig. 3
compares the wild-type with the extreme case of Tyr mutated into F5-Phe, where the hy-
droxyl group and all the four hydrogens attached to the aromatic ring are substituted by
fluorine atoms, resulting in a total loss of aromaticity; the signature of the typical negative
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charge ring totally disappeared from the electrostatic potential mapped onto an electronic
density isosurface upon fluorination as evident in Fig. 3. The decrease in hydrogen bond
strength is demonstrated by the rearrangement of the electronic density upon formation of
the hydrogen bond between serotonin and either Tyr or F5-Phe; the region affected lies in be-
tween hydrogen bond donor and acceptor with evident oscillations (charge gain/depletion)
for Tyr but no significant charge-transfer for F5-Phe, consistent with the hypothesis of a
substantially weaker bond. The electron localization functions (ELFs), which indicate where
electrons are maximally localized, show that in the tyrosine the oxygen lone pair is oriented
in the direction of the hydrogen bond with serotonin, while the fluorine lone pairs in F5-Phe
tightly surround the atoms. In fact, organic fluorine hardly forms hydrogen bonds if better
acceptors, like oxygen or nitrogen, are present; it acts as a weak hydrogen bond acceptor, like
in the calculations shown, in case of no alternatives. These calculations, although on very
simple models, helped rationalize experimental results where mutations of crucial tyrosine
residues with F5-Phe and other fluorinated unnatural amino acids produced substantially in-
creased EC50 or no response, due to the role of such tyrosines in alleged cation-pi or hydrogen
bond interactions in the serotonin binding site in 5-HT3R.28
Figure 3: Left panels: Electrostatic potential (blue positive, red negative, green neutral)
mapped onto an electronic density isosurface of 0.01 e/Å3 of the side chain of tyrosine (top)
and F5-Phe (bottom). Central panels: Electronic density differences due to the hydrogen
bond formation between serotonin and either tyrosine (top) or F5-Phe (bottom) in a reduced
model of the 5-HT3R binding site. Purple isosurfaces correspond to electronic charge gain
and orange isosurfaces to electronic charge depletion. Right panels: Electron localisation
function isosurfaces (0.85) for serotonin interacting with tyrosine (top) or F5-Phe (bottom).
[Adapted from Ref.46]
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The previously mentioned structural motif of an aromatic cage surrounding a cation
interacting with multiple aromatic residues, proposed for the binding site of pLGICs, was
also studied by DFT calculations with the M06 exchange and correlation functional,47 to-
gether with the effects of progressive ring fluorination to support the strategy used in vivo
mutagenesis experiments to probe cation-pi interactions.
As shown in Fig. 3, the analysis of the electrostatic potential of the mutated amino
acids mapped onto an electron density isosurface is a useful tool for estimating the efficiency
of an aromatic residue to perform cation-pi interactions. In general, the stronger is the
negative electrostatic potential in the ring, the stronger is the interaction: this is reflected
in the calculated binding energies.48,49 The effects of mutations in cation-pi interactions can
be qualitatively explained in simple electrostatic terms by assuming that the electrostatic
potential calculated at points located above the centre of the ring is able to predict the
strength of the interaction. However, additional effects have been suggested as important for
the description of such a complex interaction, including inductive effects over pi resonance49
and the effects of mutation on the polarization of the pi-ring.50 It has also been shown that
that the effect of mutations can be attributed to direct through-space interactions with the
substituents.51,52 An alternative description of cation-pi interaction is based on the estimate
of the interaction between the ligand monopole and the aromatic molecular quadrupole
moment;53 however, the description in terms of electric multipoles is only valid for well-
separated charge distributions.54
Within the study of pLGICs, as well as other biomolecules, first principles calculations
play also a very important role in the development of force-field parametrisations for un-
conventional ligands and unnatural amino acids to use for large simulations. For example,
we used DFT calculations (using PBE gradient-corrected exchange-correlation functional,
norm-conserving Martins-Troulliers pseudopotentials and a plane-wave basis set with a 70
Ry cutoff) to parametrise a series of proline analogues,55 which were used in experiments
to mutate a specific proline in the M2-M3 loop in 5-HT3R.56 This loop, at the interface
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between the ECD and the TMD, is believed to play a crucial role in transmitting the bind-
ing information to the channel. The mutants were chosen to favour or disfavour trans-cis
isomerisation of the prolyl peptide bond and involved modification of the number of atoms
in the Pro ring (Pip, Aze), its fluorination (c-4F-Pro, t-4F-Pro) and the addition of chemical
groups (Dmp, 2-Me-Pro, Tbp, 3-Me-Pro).56 Partial charges were calculated from first prin-
ciples and the parameters describing the relevant torsion for isomerisation were optimised
to reproduce DFT calculations. The force-field parameters were then used for enhanced
sampling calculations, as described in the relevant section.55
In summary, first principles calculations for pLGICs currently play a useful, but rather
limited supporting role. Given the size and the timescale involved in the activation processes,
these methods cannot be employed yet for fully modelling the neuroreceptors; however,
they can complement coarser (and less accurate) levels of description applied to complex
structures, and support the interpretation of experiments when subtle electronic effects are
involved. They can also be employed within hybrid QM/MM schemes, where only a portion
of the system is treated by quantum mechanical (QM) methods and the rest with classical
force-fields (MM, molecular mechanics), a combination successfully used for several biological
systems in static or dynamical calculations.57–60 Sampling time is however dominated by
the cost of the QM part. With the increasing availability of experimental structures to
build reliable models, efficient linear-scaling algorithms for electronic structure calculations
and computer power, applying QM/MM schemes to pLGICs may become more common,
especially in cases where electronic structure effects, which cannot be described by force-
fields, need to be captured within the receptors.
Classical Molecular Dynamics
Classical molecular dynamics simulations play an important role in providing information at
the molecular level for pLGICs at ambient or physiological conditions. Starting from available
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experimental structures or from homology models, the dynamics of fairly complete pLGICs
(e.g. in Refs.61–63) or portions of them, like the ECD or the TMD, (e.g. in Refs.44,64–67) can be
studied for significant times. The availability of powerful computers, MD software packages,
homology modelling software and, more recently, good resolution structures, provides the
opportunity to set up interesting simulations, accounting for the environment and mimics
of the membrane. Ligand-docking, assisted by experimental information from mutagenesis
experiments, helps locate neurotransmitters or relevant ligands in potential binding pockets,
generating initial configurations for MD simulations. Once these are carried out, information
on the network of interactions formed by the ligand can be extracted and compared with
experimental evidence. Mutations can be easily included in the models, and MD simulations
can be repeated to reproduce the work of mutagenesis experiments.64,65
For example, to complement single-channel experiments and kinetic calculations, we de-
signed a set of MD simulations to mimic mutagenesis experiments in the α7 nicotinic acetyl-
choline receptor with the goal to understand the role of a specific proline (Pro180) in the
middle of the ECD β9 strand during desensitisation, i.e. the process involving progressive
reduction of the flux of ions when the ligands are present for prolonged times.65 The sim-
ulations used a minimal homology model built on the AChBP template, with two adjacent
subunits and the AMBER2003 force-field. Pro180 was mutated with Thr, Ser, Tyr, Asp,
Gly and Phe, and simulated for a few ns at ambient temperature and pressure. In all cases
the residues at position 180 in the β9 strand formed double the number of hydrogen bonds
with the adjacent β10 strand, as shown in Fig. 4 together with typical quantities that can
be calculated from MD trajectories related to residue fluctuations, bond length distributions
and representative snapshots. The disruption of these interactions when proline is present at
position 180, due to its cyclic structure, correlates with faster desensitisation times recorded
experimentally, therefore linking molecular level details to macroscopically recorded effects
and providing insights into how this residue facilitates rapid desensitisation while its mutants
do not.
12
We also performed MD simulations (at 310 K and 1 atm for a few ns with the AM-
BER2003 force-field) for a series of mutants of the ECD of the GABAC receptor, a type of
GABAA receptor mostly located in retinal neurons with a potential role in retinal signal-
ing and disease like macular degeneration.64 The carboxylate group of GABA in zwitterionic
form is likely to bind to a positively charged residue, typically an arginine44,64,68 (here Arg104,
in the example of Fig. 2 Arg111), while its amine group is likely to be involved in cation-
pi interactions within a cage of aromatic residues. Mutating Arg104 with neutral (Ala),
negatively charged (Glu) or positively charged but less bulky (Lys) residues experimentally
resulted in a very large increase of EC50 or insensitivity up to large GABA concentrations,30
which correlates well with the MD data. These in fact revealed, at the atomistic level, the
persistence of hydrogen bonds between Arg104 and GABA for much of the MD simulation
in the wild-type, but extremely infrequent interactions when this residue was mutated to
Lys and no bonds at all when mutated to Ala or Glu.64
Many other MD simulations on a variety of pLGICs have been performed to complement
experiments and help rationalise the effects of mutations; they are often found in the liter-
ature in joint experimental and computational papers and they have various aims, such as
understanding the action of particular drugs or the role of specific residues in the receptors
(see e.g. Refs.21,69–79). Much work has been done on the bacterial channels ELIC and GLIC
due to the availability of structural information providing reliable initial templates for MD
simulations.
A recent example investigated GLIC in complex with the surgical agent propofol, which
is used for sedation.78 µs-long MD simulations at ambient conditions and electrophysiology
experiments were carried out to understand the effects of mutations in a transmembrane
binding cavity, specifically acting on residue Met205 within the M1 transmembrane helix
(shown in Fig. 5 on the left), and obtaining mutants potentiated by propofol. Anaesthetic
potentiation was associated with enhanced electrostatic interactions in membrane-accessible
sites, while inhibitory effects were linked to solvent-accessible sites. MD simulations were able
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Figure 4: Left: Model of α7 nAChR with Pro180 labelled. Right: Hydrogen bonds at
position 180 during MD simulations. Top: Average distance and standard deviation between
the amine nitrogen of the residue at position 180 in the β9 strand and the carboxylic oxygen
of Thr201 (red line) in the β10 strand, and between the amine nitrogen of Thr201 and
the carboxylic oxygen of the residue at position 180 (black line) for the wild-type Pro and
investigated mutations. Distributions of the N-O distances for the wild-type receptor (blue
line) and Pro180Thr-mutated receptor (green line). Bottom: Root mean square fluctuations
(RMSF) with respect to the average structure of the residues around the β8-β9 loop and
position 180. Two MD snapshots showing the hydrogen bonds formed by the residue at
position 180 and Thr201 for the wild-type receptor and the Pro180Thr mutant. [Adapted
from Ref.65]
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to assess the altered dynamics of the binding cavity volume upon mutations and the ligand
penetration, together with the evaluation of hydrogen bonds with the M1 helix. Other studies
based on mutagenesis electrophysiology experiments and related MD simulations were per-
formed for GLIC in complex with propofol and desflurane,72 desflurane and chlorophorm,75
halothane and thiopental,71 and for ELIC with isoflurane,76 with the goal to assess the role
of specific residues in the mechanisms of action of anaesthetics in pLGICs.
Besides anaesthetics, the interaction of pLGICs with neurotransmitters74,79 and a variety
of drugs21 have been investigated with the support of MD simulations. For example, a co-
crystal structure of ELIC in complex with chlorpromazine, an antipsychotic medication,
was determined (shown in the centre of Fig. 5).21 The chlorpromazine binding site was
identified behind the ECD β8-β9 loop, whose residues were in turn mutated to cysteine.
It was demonstrated that chlorpromazine binding at this loop is responsible for receptor
inhibition; 500 ns MD simulations of the chlorpromazine-bound and apo receptor (at 310 K
and 1 bar, with the AMBER99SB-ildn force-field) showed a ligand-induced conformational
change of the β8-β9 loop, resulting in an allosteric binding site. The action of alcohol on
pLGICs (specifically GLIC) and on specific alcohol-sensitive mutants was also investigated
with the support of MD.73,80
The X-ray structure of the open form of GLIC highlighted the contribution of rings of
hydroxylated residues facing the channel (Ser6′ and Thr2′) in the TMD;12 single-channel
electrophysiology showed that the side chain of Ser6′ (shown in Fig. 5, on the right) is
crucial for ion translocation, and 200 ns-long MD simulations, at 310 K, provided details
of the effects of these residues on the hydration of the pore. Mutations in the TMD can
also be used to enlarge the pore size or stabilise the channel open/conductive or closed/non-
conductive state: channel size and properties can be probed by MD simulations, which in
turn may suggest mutations that would determine certain effects.69,70,81
While some of the reviewed studies may seem very specific and focused on the role
of particular residues, because of structural similarities of pLGICs and the conservation
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Figure 5: Left: top view of the transmembrane domain of wild-type GLIC (PDB entry: 3P50)
with Met205 in red investigated in Ref.78 Centre: side view of the X-ray structure of ELIC
in complex with chlorpromazine (in green) (PDB entry: 5LG3) used in the work of Ref.21
Right: zoomed view of two subunits of GLIC (PDB entry: 4HFI) with Ser6′ highlighted in
yellow, used in Ref.12
of a number of key residues, the information gained can often be extrapolated to other
pLGICs. For example, the mutation of Met205 studied in Ref.78 is of general relevance due
to its proximity to Pro204, which is a conserved transmembrane residue among pLGICs and
whose hydrogen bond disrupting effect may be relevant for gating. The findings in Ref.21
were discussed in a general context with a comparison of the allosteric binding sites of the
closed, open and desensitised states of Cys-loop receptors. Results for TMD Ser6′ in GLIC21
were supported by previous mutational studies of Ser6′ and Thr2′ in nAChR.82
In summary, MD is a very powerful tool to extract atomistic information from a pLGIC
model and assess the effects of mutations at finite temperature. The reviewed selected
examples cover a variety of cases, including the investigation of orthosteric and allosteric
binding sites for neurotransmitters and drugs, specific residues in the ECD, the TMD and
the pore. However, MD is limited to timescales (typically up to µs) sufficient to sample local
free energy minima. In most cases, MD is unable to access, with affordable computational
resources, conformational states separated by energy barriers, as well as to describe acti-
vated processes like ligand binding (from the solvent) and unbinding, molecular switches,
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gating mechanisms etc., which occur on much longer timescales. Strategies to overcome this
limitation involve either the use of simplified coarse-grained models or exploiting enhanced
sampling techniques, designed to accelerate rare events, as described in the next section.
Enhanced Sampling Methods
Enhanced sampling methods aim at overcoming the inadequacies of MD simulations which
are due to limited sampling of rough free energy landscapes with local minima separated by
relatively large energy barriers, as typical of many biological processes.83
Among the many available enhanced sampling methods, metadynamics stands out for
its relative simplicity and successful applications in different fields, from condensed matter
physics, chemistry, materials science and biology. It allows to accelerate rare events and
calculate the free energy of complex polyatomic systems.84,85 Metadynamics is based on
a dimensional reduction and the identification of a small set of slowly varying variables
(collective variables, CVs) that describe the process of interest and, in particular, the minimal
free energy conformations. The molecular dynamics of the system is enhanced by adding a
history-dependent potential, built as a sum of Gaussians located at points already visited in
the selected CV space. In practice, this repulsive potential discourages the system to revisit
places already visited, encouraging it to escape local minima and sample the whole CVs
space. When the sampling is complete, the history-dependent potential provides a cast of the
underlying free energy landscape as a function of the chosen CVs. An efficient metadynamics
simulation relies on a smart choice of a few CVs, able to capture the important details of
the process of interest. Metadynamics has been successfully used by us and many others to
accelerate rare events and explore free energies in small and large biomolecules, including
systems with mutations (see e.g. Refs.55,62,68,86–96). Here we focus on its applications to
investigate mutations in pLGICs.
We used metadynamics to investigate the disruption of neurotransmitter binding in a
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GABA receptor when crucial residues were mutated.68 For this task, we considered the RDL
receptor, an insect receptor activated by GABA, which is linked to insecticide resistance
and is a potential target for insecticide design.97–99 The RDL receptor had been previously
studied by us computationally, by homology modelling to test different recipes and select
a reliable structure, ligand-protein docking guided by experimental information and MD,44
and by mutagenesis electrophysiology experiments.32,66 While these calculations, with the
support of experiments, provide information on the reliability of the atomistic model and on
the network of potential interactions that GABA may form in the receptor, as shown in Fig.2,
they depend on the reliability of the initial docked pose, give very qualitative estimations of
binding affinities through e.g. the MM/PBSA method,100 and no indication of binding and
unbinding paths. Hence, we performed metadynamics simulations on the best of the models
we built, based on an X-ray GluCl template with 38% sequence identity,15 to study the
binding and unbinding of GABA to the orthosteric binding site in the wild-type and in two
mutants, that were experimentally unresponsive.32,66 Because sampling the entire solvent
is an unrealistic task within the time simulations can afford, we used a funnel restraining
potential enclosing the binding site, as roughly identified by mutagenesis experiments and
preliminary MD simulations. The neurotransmitter could freely move within the funnel,
which was positioned as shown in Fig. 6. The funnel potential limited the exploration of the
solvent to a small cylindrical volume, whose effects on the binding affinity could be corrected
a posteriori.101 The two CVs biased in the metadynamics were: (i) the position of the centre
of mass of GABA along the funnel axis and (ii) the one along the radius orthogonal to such
axis. Simulation times of the order of µs were needed for convergence and the AMBER
ff12SB force field102 was used.
In the wild-type RDL, first the GABA carboxylate group binds from the solvent to
the positively charged Arg218, the initial point of attraction in the receptor, and then to
Arg111, to which it remains pinned, swinging its amine tail to interact with Glu204 and,
in the process, dragging the C-loop over the orthosteric binding site. GABA positioned in
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between Glu204 and Arg111 is shown in Fig. 6. Mutating either Glu204 or Arg111 with the
neutral alanine dramatically disrupts the free energy landscape, as evident in the projection
of the free energy along the funnel axis in Fig. 6. A pre-binding minimum is also noticeable
in the wild-type case, where GABA first binds to Arg111 before swinging its amine tail to
interact to Glu204, surrounded by a cage of aromatic residues. The disruption by mutations
is also clear from the energy landscape re-weighted103 with respect to the distances between
GABA charged moieties and the Cαs of the residues at position 104 and 111, also shown
in Fig. 6. In the wild-type the two isoenergetic minima correspond to binding poses where
the interaction of GABA with Glu204 was either direct or mediated by a water molecule.
In the Arg111Ala-mutated receptor, the first part of the binding process was disrupted: the
absence of Arg111 prevented GABA from finding its first stable anchoring point and entering
the binding site with optimal orientation. Alternative binding interactions only gave rise to
shallow free energy minima. In the Glu204Ala-mutated receptor, GABA carboxylate still
bound to Arg218 and Arg111, as in the wild-type receptor, but the amine group could not
form any persistent interaction due to the absence of Glu204, so the process could not be
completed. The data for the mutated receptors are consistent with weak or no binding,
when including the entropic cost of the funnel potential, in agreement with the mutagenesis
experiments which recorded non-responsive channels.32,66
We also used metadynamics to assess the effect of mutating a potential trans-cis proline
switch, which was experimentally suggested as crucial for the gating of the 5-HT3 recep-
tor.56 This proline residue (Pro8*) is located in the M2-M3 loop (shown in Fig. 1), which
is important for the transduction of the binding signal to the channel gate. Mutagenesis
electrophysiology experiments established that if this specific proline was mutated with ana-
logues that would disfavour the trans-cis isomerisation, the channel would not function.56
The proposed idea of the trans-cis switch involved in the opening of the ion channel is
intriguing, although still controversial;104,105 more experimental and computational studies
would be useful to assess it.
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Figure 6: Top left panel: Location of the funnel restraining potential with respect to two
adjacent subunits in the ECD of the RDL receptor; GABA is shown in red. Bottom left
panel: GABA binding free energy projected onto the funnel axis for the wild-type RDL
receptor and the Glu204Ala and Arg111Ala mutants. Right panels: GABA binding free
energy as a function of the distances between GABA charged groups and the Cαs of the
residues at positions 111 and 204 (as sketched in the top right corner in cyan and magenta)
for the wild-type RDL receptor (bottom left), the Glu204Ala-mutant (top left), and the
Arg111Ala-mutant (bottom right). [Adapted from Ref.68]
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We calculated the free energy surface in water solution at room temperature for a simple
dipeptide model of the switch for a number of mutants, as a function of two relevant torsional
angles, as shown in Fig.7: ξ, which accounts for both the trans-cis prolyl peptide bond
isomerisation and the coupled piramidalisation of the imide nitrogen, and ψ, which describes
the orientation of the C-terminal amide. Convergence was reached in 16 ns. The cis-
trans free energy differences relative to proline from metadynamics simulations and from
electrophysiology experimental data (derived from the EC50, for the functional wild-type
and mutated channels) show a correlation coefficient of 0.98, indicative of a relationship
between the cis and trans isomer populations and the receptor functional response. These
calculations were done for simple models, which did not take into account the receptor
environment, also because no experimental structure of 5-HT3R was available. Simulations
within the receptor are much more complex, requiring much larger systems and much longer
simulation times for convergence. We have recently calculated, for the wild-type case with
the model build from the X-ray structure of 5-HT3R17 shown in Fig. 1, how the proline
isomerisation is affected by the protein environment (with a loss of symmetry in the free
energy surface and a preferential direction for the isomerisation path), which in turns it
affects, in particular at the level of the ring the negatively charged Asp residues at the top
of the M2 helices, which act as a sort of selectivity filter for the incoming Na+ ions.106
These data represent just a few examples of how metadynamics can be used to obtain
additional information with respect to MD in the assessment of how mutations affect ligand-
binding or switching mechanisms in pLGICs. There is potential to apply this technique to
other processes involved in the chain of events leading to gating.62
Other protocols and enhanced sampling methods, from umbrella sampling to the string
method, can also be used to obtain similar or complementary information, e.g. linked to
conformational changes, ion translocations and binding kinetics in wild-type and mutated
receptors.107–109 In particular, the string method, which can be employed for computing tran-
sition pathways, free energy barriers and transition rates,110,111 has been used to investigate
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Figure 7: Free energy surfaces from metadynamics simulations, as a function of the angles
ξ and ψ shown in the bottom left panel, for proline dipeptide (top right) and a number of
mutants. [Adapted from Ref.55]
the activation of GLIC.42,112
With the increasing availability of structures in different functional states, enhanced
sampling methods can play a crucial role in elucidating the dynamics between different
functional states which is important to accurately describe the physiological behaviour of
pLGICs.
Conclusions and Perspectives
A wealth of structural information from X-ray spectroscopy and cryo-electron microscopy
and of functional data from mutagenesis electrophysiology experiments on pLGICs have
become available. More data are expected to be generated in the near future: computational
tools have a unique role to play in complementing experiments by providing insights at
different levels of accuracy and resolution. Here, we reviewed a selection of the available
computational techniques, which we, as well as others, have used to perform mutagenesis
computer experiments in pLGICs with the goal to investigate specific processes, from ligand-
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binding and modulation to residue isomerisation and channel hydration.
These techniques include first principles methods, which are useful to capture electronic
structure details, especially important within the unnatural amino acid mutation strategy.
An example is progressive fluorination of aromatic rings which disrupts aromaticity, weak-
ening cation-pi and hydrogen bond interactions; it would be difficult to describe these effects
without explicitly accounting for the electronic degrees of freedom. First principles meth-
ods are also useful for fitting force-fields for unconventional residues and ligands. However,
they are computationally costly and, hence, limited to simplified models and very reduced
sampling times.
MD simulations with classical force-fields play a fundamental role in providing atomistic
insights into partial or fairly complete pLGICs models, which are becoming more common
and reliable as experimental structures with good resolution are being determined. In fact,
the great majority of modelling work to investigate mutations in pLGICs is based on MD.
With the support of ligand-protein docking methods and the guide of experiments, MD
simulations are, for example, useful to study, at physiological or ambient conditions, ligated
receptors, assessing how the ligand-protein interaction network changes when mutations are
introduced. However, MD simulations also have shortcomings, due to the limited timescale
they can sample.
In fact, activated processes in pLGICs need enhanced sampling methods to be meaning-
fully described: here we have focussed on two examples from metadynamics simulations.
The selection of methods we reviewed here is not unique and is based on those we have
used in our work to investigate mutations in pLGICs. There are many other computational
tools used in biomolecular simulations that can be useful for investigating pLGICs and their
mutants, with on-going improvements and developments. For example, we did not discuss
coarse grained (CG) methods, which can greatly simplify the models used in MD from all
atoms to reduced number of sites, losing details but allowing more extensive sampling.113
They have been applied in some studies of pLGICs: for example, elastic network models
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were employed to explore the pathway of the gating transition in ELIC/GLIC,38,114 and
anaesthetic/pLGIC interactions were described with the MARTINI115 CG force-field.116
Methods of different resolution can in principle be combined, not only at the QM/MM
level already mentioned, but also at the MM/CG level, which have been recently tested
for membrane proteins.117 Mesoscopic and macroscopic levels may also be important to
understand how pLGICs contribute to neuronal communication. While methods of different
resolution are individually useful in the study of mutations in pLGICs as showed here,
combining them in a comprehensive computational scheme, although very challenging, may
improve the power of simulations in describing and predicting the working mechanisms of
pLGICs and the influence that mutations have on them.
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